The pathophysiology of motor fatigue and fatigability in multiple sclerosis

por Patejdl, Robert, Zettl, Uwe K.
Publicado 2022

Headaches in Multiple Sclerosis Patients Might Imply an Inflammatorial Process

por Möhrke, Jan, Kropp, Peter, Zettl, Uwe K.
Publicado 2013

Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review

por Abu-Mugheisib, Mazen, Benecke, Reiner, Zettl, Uwe K.
Publicado 2011

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

por Petereit, Hela-Felicitas, Tumani, Hayrettin, Zettl, Uwe K.
Publicado 2021

Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study

por Winkelmann, Alexander, Metze, Christoph, Zettl, Uwe K., Loebermann, Micha
Publicado 2023

Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross‐sectional study

por Rommer, Paulus S, König, Nicolaus, Sühnel, Annett, Zettl, Uwe K
Publicado 2018

The Cerebrospinal Fluid in Multiple Sclerosis

por Deisenhammer, Florian, Zetterberg, Henrik, Fitzner, Brit, Zettl, Uwe K.
Publicado 2019

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients

por Rommer, Paulus S., Weber, Martin S., Illes, Zsolt, Zettl, Uwe K.
Publicado 2020

Epileptic seizures at multiple sclerosis onset and their role in disease progression

por Grothe, Matthias, Ellenberger, David, Rommer, Paulus S., Stahmann, Alexander, Zettl, Uwe K.
Publicado 2023

Animal models of multiple sclerosis—Potentials and limitations

por Mix, Eilhard, Meyer-Rienecker, Hans, Hartung, Hans-Peter, Zettl, Uwe K.
Publicado 2010

Lethal form of a late-onset aquaporin-4 antibody-positive NMOSD related to the immune checkpoint inhibitor nivolumab

por Weiss, David, Cantré, Daniel, Zettl, Uwe K., Storch, Alexander, Prudlo, Johannes
Publicado 2021

Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort stu...

por Zettl, Uwe K, Bauer-Steinhusen, Ulrike, Glaser, Thomas, Hechenbichler, Klaus, Limmroth, Volker
Publicado 2013

Headache in the first manifestation of Multiple Sclerosis – Prospective, multicenter study

por Gebhardt, Marcel, Kropp, Peter, Jürgens, Tim P., Hoffmann, Frank, Zettl, Uwe K.
Publicado 2017

Vaccination and immunotherapies in neuroimmunological diseases

por Winkelmann, Alexander, Loebermann, Micha, Barnett, Michael, Hartung, Hans-Peter, Zettl, Uwe K.
Publicado 2022

Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany

por Henze, Thomas, von Mackensen, Sylvia, Lehrieder, Gerald, Zettl, Uwe K, Pfiffner, Carmen, Flachenecker, Peter
Publicado 2014

Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study

por Winkelmann, Alexander, Metze, Christoph, Frimmel, Silvius, Reisinger, Emil C., Zettl, Uwe K., Loebermann, Micha
Publicado 2019

Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients

por Ehler, Johannes, Koball, Sebastian, Sauer, Martin, Mitzner, Steffen, Hickstein, Heiko, Benecke, Reiner, Zettl, Uwe K.
Publicado 2015

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics

por Abdelhak, Ahmed, Hottenrott, Tilman, Mayer, Christoph, Hintereder, Gudrun, Zettl, Uwe K., Stich, Oliver, Tumani, Hayrettin
Publicado 2017

Risiken und Chancen von Immuntherapien in Zeiten der Coronavirus-2019-Pandemie

por Pawlitzki, Marc, Zettl, Uwe K., Ruck, Tobias, Rolfes, Leoni, Hartung, Hans-Peter, Meuth, Sven G.
Publicado 2020

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19

por Pawlitzki, Marc, Zettl, Uwe K., Ruck, Tobias, Rolfes, Leoni, Hartung, Hans-Peter, Meuth, Sven G.
Publicado 2020